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Meadows S, Woolf-May K, Kearney E. Metabolic Equivalents For 
Post-Myocardial Infarction Patients during a Graded Treadmill 
Walking Test.  JEPonline 2013;16(2):60-69. The current compendium 
regarding resting metabolic equivalents (METs) is based on 1 MET: 
oxygen uptake (VO2) 3.5 mL·kg
-1·min-1 is used to understand and 
define energy expenditure, aerobic capacity, and exercise intensity in 
cardiac populations. Yet, a field test has indicated it is not sufficiently 
accurate and may lend itself to implications that are potentially 
hazardous.  Therefore, the aim of this study was to determine METs 
in post-MI males during a controlled graded treadmill walking test 
(GTWT) using a comparative controlled study design. Seventeen 
male post-myocardial infarction (MI) subjects (mean  SD, 63.0  8.5, 
range 48 to 77 yrs) and 17 healthy male controls (51.9  7.7, range 41 
to 66 yrs) participated as subjects in this study. All subjects performed 
a GTWT at speeds 2.0 to 4.4 m·hr-1. Throughout the testing, the 
subjects’ VO2, heart rate, and rating of perceived exertion (RPE) were 
measured. Analysis comparing lines of regression showed that the 
METs were significantly higher (P<0.05) for post-MIs vs. the controls. 
METs differed significantly for post-MIs vs. current compendium METs 
(P<0.01), and controls vs. current compendium METs (P<0.01). Given 
that both post-MIs and controls showed significantly higher METs vs. 
the current compendium values during a GTWT, these findings bring 
into question the appropriateness of the standard use of the current 
METs in this context. 
 









The idea of using multiples of resting metabolic rate to describe different intensities of physical 
movement is by no means recent, as Howley (13) refers to the use of such a concept as far back as 
1890. Prior to the use of the current resting 1 metabolic equivalent (MET) of 3.5 mL O2∙kg
-1∙min-1 (2), 
there have been a number of different computations (10) to define resting metabolism.  Interestingly, 
Byrne et al. (10) stated that it is not clear how or when the 1 MET value of 3.5 mL∙kg-1∙min-1 was 
derived. Yet, it is a common practice for researchers to use the MET values of various activities (15) 
in different populations (20) with the understanding that the values are based on the 1 MET value of 
3.5 mL∙kg-1∙min-1 that was originally obtained from the resting oxygen uptake (VO2) of one 70 kg male 
of 40 yrs of age (13,28). Given the seemingly scant scientific evidence for the origin of this value, it is 
hard to believe how this figure has managed to achieve such widespread acceptance and application.  
 
The original intent for METs was as an activity classification system to standardize exercise 
intensities in survey research (1,2) and not, as it is often used today, to define energy expenditure, 
functional (aerobic) capacity, or physical activity (PA)/exercise intensity. METs are also widely used in 
the prescription of PA/exercise intensity for a range of populations. Despite criticism by numerous 
researchers, (10,11,17,20,24) the use of METs is widely used to determined the functional capacity 
for risky populations such as cardiac patients (3,6,9).   
 
Byrne et al. (10) looked at the resting metabolic rate (RMR) of 156 men and women with a mean age 
of 38.3 yrs and a body mass index (BMI) of 31.2 and found that RMR was 2.56 mL∙kg-1∙min-1, which is 
considerably less than the accepted Compendium 1 MET value. In addition, Woolf-May and Ferrett 
(29) observed that during an incremental 10-m shuttle walking field test (26), a group of male post-
myocardial infarction (MI) patients showed significantly greater MET values when compared to 
healthy age-matched male controls when using standard METs for walking at the same speed (4). 
This finding further questions the use of the current Compendium METs in specific populations. 
 
Therefore, given the potential risks of using none populations specific METs, the purpose of this study 
was to further investigate the MET values of cardiac patients using the current Compendium 1 MET 
and determine if this value differed from the current published Compendium of Physical Activity 





Seventeen uncomplicated non-smoking post-MI males were recruited from local phase IV exercise 
cardiac rehabilitation (CR) groups in the Medway, Kent area (UK). Phase IV is where cardiac patients 
are deemed sufficiently stable and able to exercise independently within the community. Seventeen 
apparently healthy non-smoking controls were also recruited from the same area. Interested 
individuals were sent an information sheet and were required to self-complete a health and PA 
screening questionnaire. Volunteers were excluded if they failed to understand the nature of the study 
and/or failed to gain their GPs approval to participate. Once approved, and prior to any assessments, 
written informed consent was obtained. The local NHS and Canterbury Christ Church University 
Research Ethics Committees approved this study. Subject characteristics are displayed in Table 1. 
 
Assessments 
Assessments were scheduled for early afternoon (30). The subjects were informed that during the 24 




to eat and/or consume caffeine during the preceding 2 hrs; drinking water was permitted. Where 
relevant, subjects were instructed to take their medications as usual. 
 
On two separate occasions each subject visited the Exercise Testing Laboratory at the University of 
Kent, Medway campus.  Visit 1 was for protocol familiarization and to ask questions.  On arrival each 
subject’s height (Stadiometer Seca 220, Hamburg, Germany) and weight (Seca 710, Hamburg, 
Germany) were measured, body mass index (BMI) was calculated. Each subject then sat quietly for 
10 min, resting blood pressure (BP) (Yamasu Mercurial Spygmomanometer 605P, Kenzmedico, 
Japan) and heart rate (HR) (beat·min-1) (Polar Model S810, Kempele, Finland) were recorded. The 
subjects were not permitted to perform the GTWT if BP exceeded 180 mmHg systolic (SBP) and 100 
mmHg diastolic (SBP) or resting HR > 100 beats.min-1 (5). 
 




     Post-MIs  (N =17) 
 




    
   **63 ± 8.50 [48 - 77] 
   
  51.9 ± 7.70 [41 - 66] 
Height (m)    1.76 ± 0.05 [1.64 - 1.84]   1.77 ± 0.04 [1.73 - 1.79] 
Body mass (Kg)   *88.8 ± 13.4 [64.0 - 111.8]   79.2 ± 11.9 [6.5 - 105.5] 
BMI (kg·m-2)   *28.6 ± 4.30 [20.5 - 38.7]   25.4 ± 4.10 [20.8 - 35.6] 
Pre-exercise resting SBP (mmHg)  127.9 ± 11.1 [96 - 150] 130.5 ± 14.1 [108 - 154] 
Pre-exercise resting DBP (mmHg)    76.8 ± 11.5 [62 - 110]   83.4 ± 10.6 [66 -102] 
PA·wk-1 
 30 min sessions at moderate intensity 
 20 min sessions at vigorous intensity 
 
 **4.59 ± 1.42 [2 - 7] 
    2.41 ± 1.58 [0 - 6] 
 
  2.82 ± 1.78 [0 - 5] 
  2.06 ± 1.98 [0 - 5] 














Clopidogrel 3  
β-blocker 13  
Statin 17 1 
Cholesterol absorption inhibitor 1  
ACE inhibitor 14 1 
Angiotensin receptor antagonist 1  
Calcium channel blocker 2  




*Significantly different at P<0.05 from the controls. **Significantly different at P<0.01 from the 
controls. 
 
Graded Treadmill Walking Test (GTWT) 
The GTWT protocol was devised to be within the subject’s functional capacity, taking into account 




has been shown to take around 2 to 3 min (12,25,27).  It has been identified that where there are 
large increments in the stages of a graded exercise test and/or if the participant is in poor physical 
condition, there are difficulties for VO2 to keep pace with each stage of the test (27). Therefore, the 
test was set at 0% gradient and speed increased by 0.3 m∙h-1 every 3 min from a starting speed of 
2.0 m·h-1 to 4.4 m∙h-1 (Table 2). Each subject was fitted with a facemask (Hans Rudolph Adult Mask, 
8930 / 8940 Series, Kansas, USA) covering the mouth and nose to collect expired air.  Expired air 
was analysed breath-by-breath using an online system (Quark b2, Cosmed, Rome, Italy) to determine 
VO2. Heart rate was simultaneously recorded by a heart rate monitor (Polar HRM S810, Kempele, 
Finland). Each subject mounted the treadmill (h/p/cosmos Saturn 4.0, Traunstein Germany) and 
performed the GTWT without holding onto the handrail.  During the GTWT the mean of these 
variables were recorded during the final minute of each stage and recorded for analysis. 
 
 




    Time (min) 
 
      Speed (m∙h-1) (km∙h-1) 
 
    Compendium METs for walking 
    on firm level surface (2) 
 
 
1 0 – 3 2.0 (3.2)                        2.50  
2 4 – 6 2.3 (3.7)                        2.80  
3 7 – 9 2.6 (4.2)                        3.06  
4 10 – 12 2.9 (4.7)                        3.24  
5 13 – 15 3.2 (5.2)                        3.50  
6 16 – 18 3.5 (5.6)                        3.80  
7 19 – 21 3.8 (6.1)                        4.52  
8 22 – 24 4.1 (6.6)                        5.26  
9 25 – 27 4.4 (7.1)                        6.04  
The protocol speeds not reported in Ainsworth et al. (2) were estimated using linear interpolation, 
METs = 1.2103.m·h-0.104; R2=0.92.  
 
Since CR patients are frequently prescribed beta-blockers, which reduces their HR, this factor was 
not relied upon to assess exercise intensity. In accordance with ACPICR (6) guidelines, the Borg 6 -
20 scale (8) subjective ratings of perceived exertion (RPE) were recorded in the final minute of each 
test stage.  In all cases the GTWT was terminated at volitional fatigue.  
 
Statistical Analysis 
In order to achieve sufficient participant numbers at an alpha of 5% and 90% power, continual 
retrospective power analysis was conducted using Clinstat statistical program by Martin Bland 
(version 08.05.96). This was based on mean inter-group differences at the various GTWT stages of 
0.22 ± 0.11 mL∙kg-1∙min-1. 
 
Statistical analysis was carried out using Minitab statistical package (version 16), with a 5% level of 
significance and variability within a distribution as one standard deviation (mean ± SD). Inter and 
intra-group differences were compared by one way analysis of variance (ANOVA).  The MET versus 
walking speed relationship was determined using analysis comparing two linear regression lines.  
 
Pearsons Product Moment correlation and regression analyses were used to determine relationships 
between factors.  Guideline MET values were taken directly from compendium values (2) for walking 




estimated using linear interpolation (Table 2). Non-parametric alternatives to the above were 




Cardiovascular Disease Risk Factors (CVD) 
Basic analysis of the CVD risk factors include the subjects’ family history of death from heart attack 
by the age 50 yrs, diabetes, elevated BP, elevated total cholesterol, obesity, and smoking. The post-
MIs demonstrated a total of 28 while the subjects in the control had a total of 7. 
 
Post-MIs 
The subjects were tested at a mean 2.7 ± 1.6 yrs post-MI. None of the medications had any 
statistically significant effect on VO2 (mL·kg
-1·min-1).  
 
GTWT Post-MIs vs. Controls (Table 1) 
The post-MI subjects showed significantly higher VO2 (mL·kg
-1·min-1) and METs compared to the 
controls (F=5.25, P<0.05) and (F=5.25, P<0.05), respectively, at treadmill-walking speeds of 2.0 to 






Figure 1. MET vs. Walking Speed Relationship during the GTWT for Post-MIs vs. Controls. 
*Statistically significantly different from the controls at P<0.05. 
 
 
GTWT Post-MIs vs. Compendium METs 
Mean post-MI METs for each GTWT stage was compared to compendium METs of same speed 





GTWT Controls vs. Compendium METs 
Mean control METs for each GTWT stage was compared to compendium METs of same speed 




Figure 2. MET vs. Walking Speed Relationship during the GTWT for Post-MIs vs. Controls vs. 
Compendium Values. *Statistically significantly different from controls at P<0.05; ŦStatistically significantly different 





The findings of this study indicated that compared to the controls the post-MIs VO2 mL∙kg
-1∙min-1 and 
subsequent METs were significantly higher during the GTWT at walking speeds of 2.0 to 4.4 m·h-1.  It 
was unfortunate that the two groups were not matched for age and body mass, and while body mass 
was accounted for within the MET calculation, age was not. The increased mean age of the post-MIs 
may have been a contributing factor in the differences observed in METs between the groups. For 
example, Morris et al. (20) observed that between a group of non-cardiac patients, referred for other 
clinical reasons, and a group of apparently healthy individuals (mean age = 57, range 21 to 89 yrs), 
the decline in maximal HR and METs with age was steeped in the referral group.    
 
Another contributing factor for the difference in METs between the post-MIs and the controls may be 
associated with the increased number of co-morbidities seen in the post-MIs. Peterson et al. (21) for 
instance considered the number of multiple co-morbidities to be the cause of difference in MET 
requirements when using a standard MET calculation, as opposed to a multiple of RMR. However, 
Byrne et al. (10) established that differences in body composition accounted for 62% of the variance 
in resting VO2 measures in healthy men and women. It is difficult to determine if body composition 




for.  Nonetheless, similar to the findings of this study (see Figure 2), Bassett et al. (7) and Kozey et al. 
(16) both compared their measured MET values during various physical activities with reported 
compendium MET values (2) and observed over 60% of the physical activities tested resulted in 
significantly higher MET values than those indicated in the established MET tables.   
 
Despite the post-MIs reporting higher PA levels than the controls, not all of the  post-MIs  reached 
stage 8 (4.1 m·h-1, Post-MI N = 15, controls N = 17) and stage 9 (4.4 m·h-1, post-MIs N = 7, controls 
N = 16). Superior levels of fitness have been shown to result in reduced oxygen consumption at 
comparable workloads (18,19), which was not seen in this study. However, if the post-MIs were 
indeed physically fitter than the controls of this study it may be that any physical fitness of the post-
MIs was negated by the younger age of the controls.  
 
None of the subjects exceeded 4.4 m·h-1 (7.8 km·h-1) during the GTWT.  However, beyond 4.4 m·h-1 
research has shown that participants find it more comfortable to run (22). Given the present study 
looked at walking, for some of the more capable subjects this might have been a limiting factor. 
However, in the study conducted by Woolf-May and Ferrett (29), none of the N = 31 male post-MI 
patients exceeded 4.16 m·h-1 (6.7 km·h-1) during the shuttle walking test (26). Yet, it is clear that the 
subjects’ mean RER and RPE values during the final stages of the GTWT in the present study are 
consistent with the subjects functional peak rather a maximum (Table 3). 
 




  Post-MIs   
 
  Controls  
  
 
Stage 8 (4.1 m·h-1) (6.6 km·h-1) 
    
   N = 15 
    




0.96 ± 0.11  
 
0.91 ± 0.06 
RPE 13.7 ± 1.7 13.4 ± 1.1 
 




0.93 ± 0.11 
 
0.94 ± 0.05 
RPE 14.3 ± 2.4 15.7 ± 2.5 
 
 
Despite medications not having any statistically significant effect on VO2 mL·kg
-1·min-1, 82% of the 
subjects in the post-MI group were taking beta-blockers and while other studies have also found beta-
blockers not to influence submaximal VO2 (14,23), beta-blockers have been found to influence VO2 
max (23). Therefore, this variable may have affected the post-MIs ability to complete the latter stages 
of the GTWT.   
 
In terms of the practical implications for prescribing exercise to post-MIs, by inserting walking speeds 
of 2, 3, and 4 m·h-1 into the equations given from each group (Figure 1), these would produce the 
MET values displayed in Table 4. For the post-MIs this would over prescribe the exercise intensity by 
around 0.5, 0.4, and 0.4 METs, respectively. Hence, it seems reasonable (for safety reasons) to take 
into consideration this “slight” adjustment in metabolic work for post-MIs when prescribing walking 























Controls 2.4 3.7 5.0 





When using the standard compendium 1 MET value to determine MET values during a GTWT, the 
post-MI subjects displayed significantly higher MET values compared to the subjects in the control 
group without CVD, and both post-MIs and controls individually showed significantly greater MET 
values compared to the current compendium MET values. In practical terms, these differences were 
less than 0.5 of a MET. Nonetheless, this difference should be considered when prescribing walking 
exercise based on current compendium MET values (particularly for high risk individuals in order to 
avoid over exertion).    
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